Industry News
The role played by estrogen in colon cancer prevention, treatment
Oct 23, 2013
As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston (UH) professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute (NCI) to investigate the mechanistic basis for novel colon cancer prevention and therapy... Read More
Internet usage linked to cancer prevention behavior
Oct 23, 2013
Internet usage is often associated with teenagers overindulging in computer games, but it may have health benefits for older users. New research shows that older internet users are more likely to take part in colorectal cancer screening projects than non-users... Read More
Resistance to certain anticancer drugs may be overcome by new nanopharmaceutical
Oct 23, 2013
The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation therapy, according to clinical trial results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23... Read More
How cancer cells get energy and raw materials for growth from glucose opens doors to new therapies
Oct 23, 2013
Ludwig researchers have elucidated a key mechanism by which cancer cells change how they metabolize glucose to generate the energy and raw materials required to sustain runaway growth... Read More
New method safely delivers potent anti-cancer compound
Oct 23, 2013
Researchers at the University of California, San Diego School of Medicine have discovered a way to effectively deliver staurosporine (STS), a powerful anti-cancer compound that has vexed researchers for more than 30 years due to its instability in the blood and toxic nature in both healthy and cancerous cells... Read More
BRCA-related breast and ovarian cancers showing early response to Investigational PARP inhibitor
Oct 23, 2013
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23... Read More
The role played by estrogen in colon cancer prevention, treatment
Oct 23, 2013
As the second leading cause of cancer-related deaths in the U.S., colon cancer affects both men and women and is expected to cause more than 50,000 deaths this year. University of Houston (UH) professor Cecilia Williams has been awarded a $1.56 million grant from the National Cancer Institute (NCI) to investigate the mechanistic basis for novel colon cancer prevention and therapy... Read More
Molecular switch identified that suppresses development of liver cancer
Oct 23, 2013
A team of scientists from the National University of Singapore (NUS) has found that activating a family of small protein, known as Rho, could suppress liver malignancies. This is the first time that a research group has provided evidence to show that the signaling crosstalk between different protein switches has an influence on the development of cancer tissues... Read More
Internet usage linked to cancer prevention behavior
Oct 23, 2013
Internet usage is often associated with teenagers overindulging in computer games, but it may have health benefits for older users. New research shows that older internet users are more likely to take part in colorectal cancer screening projects than non-users... Read More
Insufficient vitamin D may raise anemia risk in children
Oct 22, 2013
New research led by investigators at the Johns Hopkins Children's Center suggests that children who do not get enough vitamin D may be at higher risk for anemia. However, they caution that while their findings show a strong link, it does not mean one causes the other... Read More
Previous Page Next Page